Refine by
Infection Treatment Articles & Analysis: Older
24 news found
"FDA provided clear guidance and considered the program outlined by MerLion for the development of finafloxacin towards potential licensure for the treatment of infections caused by Burkholderia pseudomallei - for both a naturally occurring and biodefense-related melioidosis indication - feasible," said Dr. ...
To discover the more advantages of VelaShape body slimming machine, talk to a friendly member of our team. Velashape cellulite treatment can help improve the look and feel of skin. What is VelaShape treatment? ...
The funding project is titled “Pravibismane Suspension as a Topical, Broad Spectrum Anti-Infective Wound Care Treatment and Prevention for Combat Injury-Related Infections”. ...
(CCHCI) today announced a collaboration with The Body Agency Collective (TBAC) and Visby Medical, Inc., to improve sexually transmitted infection (STI) diagnosis and treatment in observance of National STD Awareness Week. ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
Multi-virus prevention has the potential to transform the management of transplant patients, who currently have limited to no approved treatment options for these infections that threaten patient survival. ...
ByKalaris
In a significant step forward, new data shows that BIT225 protects from severe disease even when started once there is an established infection. Mice commencing treatment with BIT225 after infection with SARS-CoV-2 had similar levels of protection against severe disease as mice commencing treatment with BIT225 prior to ...
The data confirm the potential of V-306 for prophylaxis against Respiratory Syncytial Virus (RSV) infection, possibly using a convenient needle-free method of vaccination. ...
Kephera Diagnostics announced today the launch of a quantitative test to measure the level of antibodies elicited by vaccination against COVID-19, as well as by COVID-19 infection. The test will be available as a service through Kephera’s CLIA-certified laboratory. ...
The EB003 CRISPR-based killing mechanism also abolished Shiga-toxin production, compared to antibiotic treatment, which can on the contrary lead to Shiga-toxin overproduction. ...
Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, today announced the expansion of its leadership team with the appointment of a Chief Scientific Officer and two additional Board members. ...
The current standard of care is ablation with curettage, an effective treatment, but with several side effects including scarring, changes in pigmentation, pain, bleeding, and risk of wound infection; alternative treatments include electrosurgery or cryosurgery, which are not as effective as curettage. ...
The technologies developed by the RCSI Tissue Engineering Research Group have extensive pre-clinical and human data demonstrating their effectiveness in the treatment of both hard and soft tissues. The RCSI licensing deal includes best in class, proprietary, natural collagen-based delivery technologies, which have been developed into products for the regeneration of bone, the ...
Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and oncology diseases, announced today the completion of initial vaccination of the first dose cohort in the Phase 1 healthy volunteer study of V-306, its candidate vaccine for prophylaxis of RSV (Respiratory ...
Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering small protein therapeutics, today announced that it is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP), to support the development of Orion’s lead compound, OB-002, a promising ...
Most infections present as a syndrome, with signs and symptoms that are common to many pathogens. ...
Nanovis’ technology driven growth strategy is based on its FortiCore, nanotube, and NanoPEEK fixation technology platform and it’s bactericidal nanotube and infection prevention and treatment technology platform. The FortiCore scaffold, sold in other orthopedic markets as the OsteoSync™ scaffold by the inventors of the technology, Sites Medical, ...
ByNanovis
The idea is simple: when a patient has a bacterial infection, doctors should find out what kind of bacteria it is so they can give the most effective treatment. ...
The study, conducted at the clinical lab of a large urgent care facility in Seattle, compared the current standard treatment approach of urinary tract infections (UTIs) with treatment options based on ID Genomics’ technology, which quickly identifies the likely resistance profile of each patient’s infection. The ...
Patent and Trademark Office allowed a new patent, BONE IMPLANTS FOR THE TREATMENT OF INFECTION. The company also announced that it has made an expedited CE Mark filing for a significantly expanded OrthoFuzIon Antimicrobial Bone Screw System product line. ...